Determination of Pre/Post Treatment Changes in Prostate Specific Antigen Levels in Patients with Acute Prostatitis
Journal Title: Translational Research in Urology - Year 2022, Vol 4, Issue 1
Abstract
Introduction: Given that studies on the association between pre/post-treatment PSA levels in acute prostatitis are limited and investigations in men from different communities are few, the present study aimed to determine the pre/post-treatment changes in the prostate-specific antigen (PSA) levels in patients with acute prostatitis. Method: The current cross-sectional study was conducted in 2020 on a population of men with acute prostatitis. The patients were then referred to a laboratory to measure PSA levels for a definitive diagnosis of acute prostatitis. Prostate volume was determined using ultrasound. Afterward, drug treatment was started for the patient, followed by monitoring. The PSA levels were re-measured, and prostate volume was recorded after treatment. Patient information included patient profile, age, date of the first visit, PSA level at the baseline (before treatment), diagnosis of acute prostatitis, time to start treatment, time to end treatment, PSA level after treatment, and prostate volume. Results: The mean and standard deviation of the age of these patients was 59.90±6.31 years old. The results showed a significant relationship between age and primary PSA at the beginning of diagnosis and PSA reduction. (P-value<0.05). There is a significant relationship between age and duration of treatment (P-value=0.001). The duration of treatment was significantly related to the reduction of PSA, the amount of primary PSA at the beginning of diagnosis, and the amount of secondary PSA after treatment (P-value<0.05). Conclusion: The study's findings can be concluded that the duration of treatment can effectively reduce the level of PSA in patients with acute prostatitis. Extensive studies with a control group for future studies are recommended. Graphical Abstract
Authors and Affiliations
Hamid Mazdak; Zahra Zandi Mashhadi; Kia Nouri Mahdavi; Reza Kazemi
Keywords
Related Articles
- EP ID EP704307
- DOI 10.22034/TRU.2022.323475.1097
- Views 100
- Downloads 0
Biomarkers for Prostate Cancer Diagnosis from Genetic Perspectives
Prostate cancers (PC) are mainly diagnosed by screening prostate-specific antigen (PSA) quantity in the blood or a digital rectal exam (DRE). PC typically does not have symptoms contrary to advanced cancers that are diag...
Comparison of the Tamsulosin and Tolterodine Effectiveness in Stent-Related Symptoms Reduction
Introduction To compare the effectiveness of tamsulosin and Tolterodine in reducing stent-related symptoms with each other and with the control group we performed this randomized clinical trial. Methods 150 patients a...
Association of Microbiota and Overactive Bladder: A Mini Literature Review
Overactive bladder (OAB) is a common urinary disorder that affects both sexes. This disorder has a very strong and direct effect on the quality of the personal and social life of patients. Some recent studies have shown...
Homeostatic Efficacy of Microporous Polysaccharide Hemosphere in Post-Operative Complications Reduction of Tubeless Percutaneous Nephrolithotomy
Introduction Current hemostatic agents are needed to reduce bleeding and transfusion during several surgery processes. Plant-based absorbable surgical hemostatic agents (microporous polysaccharide hemospheres) are propo...
A Rare Case of Fournier Gangrene after a Colostomy Closure
Introduction: Fournier gangrene is a surgical emergency that presents as necrotizing fasciitis. It mainly involved the genital and perineal regions. The predisposing factors are immunosuppression, diabetes mellitus, alco...